[Preliminary results of myelobromol treatment of chronic granulocytic leukemia].
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001966:Bromine / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D004361:Drug Tolerance; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D007958:Leukocyte Count; D008353:Mannitol / Q000627:therapeutic use*; D008875:Middle Aged; D013997:Time Factors; D014050:Toluene
D000970:Antineoplastic Agents; D014050:Toluene; D008353:Mannitol; D002066:Busulfan; D001966:Bromine
Wstepne wyniki leczenia myelobromolem białaczki granulocytowej przewlekłej.